Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Increases in body mass index and cardiovascular risk factors during methadone maintenance treatment.

Sweeney MM, Antoine DG, Nanda L, Géniaux H, Lofwall MR, Bigelow GE, Umbricht A.

J Opioid Manag. 2019 Sep/Oct;15(5):367-374. doi: 10.5055/jom.2019.0526.

PMID:
31849028
2.

[Smoking cessation: Overcoming "nicotinophobia" in patients … and prescribers?]

Galera O, Antoine D, Soukarie L, Huet I, Bajon D.

Presse Med. 2019 Dec;48(12):1368-1369. doi: 10.1016/j.lpm.2019.11.009. French. No abstract available.

PMID:
31822337
3.

Personal trauma among healthcare providers: implications for screening practices.

Cooper C, Coleman J, Irvin N, Lee A, Antoine D.

Women Health. 2019 Oct 31:1-15. doi: 10.1080/03630242.2019.1683122. [Epub ahead of print]

PMID:
31665985
4.

HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.

Khambu B, Huda N, Chen X, Antoine DJ, Li Y, Dai G, Köhler UA, Zong WX, Waguri S, Werner S, Oury TD, Dong Z, Yin XM.

J Clin Invest. 2019 May 1;129(5):2163. doi: 10.1172/JCI129234. Epub 2019 May 1. No abstract available.

5.

HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.

Khambu B, Huda N, Chen X, Antoine DJ, Li Y, Dai G, Köhler UA, Zong WX, Waguri S, Werner S, Oury TD, Dong Z, Yin XM.

J Clin Invest. 2019 May 1;129(5):2163. doi: 10.1172/JCI129233. Epub 2019 May 1. No abstract available.

6.

Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy.

Walker LE, Frigerio F, Ravizza T, Ricci E, Tse K, Jenkins RE, Sills GJ, Jorgensen A, Porcu L, Thippeswamy T, Alapirtti T, Peltola J, Brodie MJ, Park BK, Marson AG, Antoine DJ, Vezzani A, Pirmohamed M.

J Clin Invest. 2019 Apr 8;129(5):2166. doi: 10.1172/JCI129285. eCollection 2019 Apr 8. No abstract available.

7.

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

Hernandez C, Huebener P, Pradere JP, Antoine DJ, Friedman RA, Schwabe RF.

J Clin Invest. 2019 Apr 1;129(4):1803. doi: 10.1172/JCI128262. Epub 2019 Apr 1. No abstract available.

8.

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

Hernandez C, Huebener P, Pradere JP, Antoine DJ, Friedman RA, Schwabe RF.

J Clin Invest. 2019 Apr 1;129(4):1803. doi: 10.1172/JCI128261. Epub 2019 Apr 1. No abstract available.

9.

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.

Huebener P, Pradere JP, Hernandez C, Gwak GY, Caviglia JM, Mu X, Loike JD, Jenkins RE, Antoine DJ, Schwabe RF.

J Clin Invest. 2019 Mar 4;130:1802. doi: 10.1172/JCI126976. eCollection 2019 Mar 4. No abstract available.

10.

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis.

Huebener P, Pradere JP, Hernandez C, Gwak GY, Caviglia JM, Mu X, Loike JD, Jenkins RE, Antoine DJ, Schwabe RF.

J Clin Invest. 2019 Mar 4;130:1802. doi: 10.1172/JCI126975. eCollection 2019 Mar 4. No abstract available.

11.

Inflammatory periosteal reaction on ribs associated with lower respiratory tract disease: A method for recording prevalence from sites with differing preservation.

Davies-Barrett AM, Antoine D, Roberts CA.

Am J Phys Anthropol. 2019 Mar;168(3):530-542. doi: 10.1002/ajpa.23769. Epub 2019 Jan 5.

12.

Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes.

Yang H, Wang H, Levine YA, Gunasekaran MK, Wang Y, Addorisio M, Zhu S, Li W, Li J, de Kleijn DP, Olofsson PS, Warren HS, He M, Al-Abed Y, Roth J, Antoine DJ, Chavan SS, Andersson U, Tracey KJ.

JCI Insight. 2018 Dec 20;3(24). pii: 126617. doi: 10.1172/jci.insight.126617. No abstract available.

13.

Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes.

Yang H, Wang H, Levine YA, Gunasekaran MK, Wang Y, Addorisio M, Zhu S, Li W, Li J, de Kleijn DP, Olofsson PS, Warren HS, He M, Al-Abed Y, Roth J, Antoine DJ, Chavan SS, Andersson U, Tracey KJ.

JCI Insight. 2018 Dec 20;3(24). pii: 126616. doi: 10.1172/jci.insight.126616. No abstract available.

14.

Double jeopardy: a review of weight gain and weight management strategies for psychotropic medication prescribing during methadone maintenance treatment.

Schlienz NJ, Huhn AS, Speed TJ, Sweeney MM, Antoine DG.

Int Rev Psychiatry. 2018 Oct;30(5):147-154. doi: 10.1080/09540261.2018.1509843. Epub 2018 Nov 6. Review.

15.

Comorbid chronic pain and opioid use disorder: literature review and potential treatment innovations.

Speed TJ, Parekh V, Coe W, Antoine D.

Int Rev Psychiatry. 2018 Oct;30(5):136-146. doi: 10.1080/09540261.2018.1514369. Epub 2018 Nov 6. Review.

PMID:
30398071
16.

Potentially preventable tuberculosis cases in children exposed to a contaminant case.

Ollier V, Antoun F, Thouvenin G, Faye A, Kone-Paut I, Benoist G, Antoine D, Charlois C, Delacourt C.

Arch Pediatr. 2018 Oct;25(7):421-425. doi: 10.1016/j.arcped.2018.07.001. Epub 2018 Sep 13.

PMID:
30220523
17.

Effect of feed intake level on the body temperature of pigs exposed to heat stress conditions.

Cervantes M, Antoine D, Valle JA, Vásquez N, Camacho RL, Bernal H, Morales A.

J Therm Biol. 2018 Aug;76:1-7. doi: 10.1016/j.jtherbio.2018.06.010. Epub 2018 Jun 25.

PMID:
30143283
18.

Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective.

Athersuch TJ, Antoine DJ, Boobis AR, Coen M, Daly AK, Possamai L, Nicholson JK, Wilson ID.

Toxicol Res (Camb). 2018 Mar 6;7(3):347-357. doi: 10.1039/c7tx00340d. eCollection 2018 May 8. Review.

19.

Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency.

Ricordel M, Foloppe J, Antoine D, Findeli A, Kempf J, Cordier P, Gerbaud A, Grellier B, Lusky M, Quemeneur E, Erbs P.

Cancers (Basel). 2018 Jul 10;10(7). pii: E231. doi: 10.3390/cancers10070231.

20.

High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.

Ge X, Arriazu E, Magdaleno F, Antoine DJ, Dela Cruz R, Theise N, Nieto N.

Hepatology. 2018 Dec;68(6):2380-2404. doi: 10.1002/hep.30093. Epub 2018 Nov 13.

21.

TEMPORARY REMOVAL: Reference intervals for putative biomarkers of drug-induced liver injury and liver regeneration in healthy human volunteers.

Francis B, Clarke JI, Walker LE, Brillant N, Jorgensen AL, Park BK, Pirmohamed M, Antoine DJ.

J Hepatol. 2018 May 3. pii: S0168-8278(18)32042-7. doi: 10.1016/j.jhep.2018.04.024. [Epub ahead of print]

PMID:
29729369
22.

Evaluation of sea-surface photosynthetically available radiation algorithms under various sky conditions and solar elevations.

Somayajula SA, Devred E, Bélanger S, Antoine D, Vellucci V, Babin M.

Appl Opt. 2018 Apr 20;57(12):3088-3105. doi: 10.1364/AO.57.003088.

PMID:
29714341
23.

Evaluation of plasma microRNA-122, high-mobility group box 1 and keratin-18 concentrations to stratify acute gallstone disease: a pilot observational cohort study in an emergency general surgery unit.

Th'ng F, Vliegenthart B, Lea JD, Antoine DJ, Dear JW, Mole DJ; Edinburgh Emergency Surgery Study Group, Royal Infirmary of Edinburgh, NHS Lothian.

BMJ Open. 2018 Apr 27;8(4):e020061. doi: 10.1136/bmjopen-2017-020061.

24.

Systems Toxicology Approach to Identifying Paracetamol Overdose.

Mason CL, Leedale J, Tasoulis S, Jarman I, Antoine DJ, Webb SD.

CPT Pharmacometrics Syst Pharmacol. 2018 Jun;7(6):394-403. doi: 10.1002/psp4.12298. Epub 2018 Apr 18.

25.

Urinary Biomarkers of Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin.

McWilliam SJ, Antoine DJ, Jorgensen AL, Smyth RL, Pirmohamed M.

Sci Rep. 2018 Mar 23;8(1):5094. doi: 10.1038/s41598-018-23466-4.

26.

HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.

Khambu B, Huda N, Chen X, Antoine DJ, Li Y, Dai G, Köhler UA, Zong WX, Waguri S, Werner S, Oury TD, Dong Z, Yin XM.

J Clin Invest. 2018 Jun 1;128(6):2419-2435. doi: 10.1172/JCI91814. Epub 2018 May 7. Erratum in: J Clin Invest. 2019 May 1;129(5):2163.

27.

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

Hernandez C, Huebener P, Pradere JP, Antoine DJ, Friedman RA, Schwabe RF.

J Clin Invest. 2018 Jun 1;128(6):2436-2451. doi: 10.1172/JCI91786. Epub 2018 May 7. Erratum in: J Clin Invest. 2019 Apr 1;129(4):1803.

28.

Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke.

Roth S, Singh V, Tiedt S, Schindler L, Huber G, Geerlof A, Antoine DJ, Anfray A, Orset C, Gauberti M, Fournier A, Holdt LM, Harris HE, Engelhardt B, Bianchi ME, Vivien D, Haffner C, Bernhagen J, Dichgans M, Liesz A.

Sci Transl Med. 2018 Mar 14;10(432). pii: eaao1313. doi: 10.1126/scitranslmed.aao1313.

PMID:
29540615
29.
30.

Syndemic of Lifetime Mental Illness, Substance Use Disorders, and Trauma and Their Association With Adverse Perinatal Outcomes.

McDonald LR, Antoine DG, Liao C, Lee A, Wahab M, Coleman JS.

J Interpers Violence. 2020 Jan;35(1-2):476-495. doi: 10.1177/0886260516685708. Epub 2017 Jan 6.

PMID:
29294630
31.

Magnesium deficiency affects HNF1β expression in rat liver in vivo and in vitro.

Martin H, Antoine D, Coste-Sarguet L, Seydou Sarr F, Richert L, Berthelot A.

Magnes Res. 2017 Aug 1;30(3):98-105. doi: 10.1684/mrh.2017.0428.

PMID:
29256409
32.

Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies.

Dear JW, Clarke JI, Francis B, Allen L, Wraight J, Shen J, Dargan PI, Wood D, Cooper J, Thomas SHL, Jorgensen AL, Pirmohamed M, Park BK, Antoine DJ.

Lancet Gastroenterol Hepatol. 2018 Feb;3(2):104-113. doi: 10.1016/S2468-1253(17)30266-2. Epub 2017 Nov 14.

33.

Repurposing Statins for Renal Protection: Is It a Class Effect?

McWilliam SJ, Antoine DJ, Pirmohamed M.

Clin Transl Sci. 2018 Mar;11(2):100-102. doi: 10.1111/cts.12521. Epub 2017 Nov 15. No abstract available.

34.

Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature.

Caparrotta TM, Antoine DJ, Dear JW.

Eur J Clin Pharmacol. 2018 Feb;74(2):147-160. doi: 10.1007/s00228-017-2356-6. Epub 2017 Oct 24. Review.

35.

High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy.

Ravizza T, Terrone G, Salamone A, Frigerio F, Balosso S, Antoine DJ, Vezzani A.

Brain Behav Immun. 2018 Aug;72:14-21. doi: 10.1016/j.bbi.2017.10.008. Epub 2017 Oct 13. Review.

PMID:
29031614
36.

Cowpox Virus: A New and Armed Oncolytic Poxvirus.

Ricordel M, Foloppe J, Pichon C, Sfrontato N, Antoine D, Tosch C, Cochin S, Cordier P, Quemeneur E, Camus-Bouclainville C, Bertagnoli S, Erbs P.

Mol Ther Oncolytics. 2017 Aug 24;7:1-11. doi: 10.1016/j.omto.2017.08.003. eCollection 2017 Dec 15.

37.

Sclerosing angiomatoid nodular transformation of the spleen mimicking metastasis of melanoma: a case report and review of the literature.

Demirci I, Kinkel H, Antoine D, Szynaka M, Klosterhalfen B, Herold S, Janßen H.

J Med Case Rep. 2017 Sep 3;11(1):251. doi: 10.1186/s13256-017-1400-6.

38.

Dynamic and accurate assessment of acetaminophen-induced hepatotoxicity by integrated photoacoustic imaging and mechanistic biomarkers in vivo.

Brillant N, Elmasry M, Burton NC, Rodriguez JM, Sharkey JW, Fenwick S, Poptani H, Kitteringham NR, Goldring CE, Kipar A, Park BK, Antoine DJ.

Toxicol Appl Pharmacol. 2017 Oct 1;332:64-74. doi: 10.1016/j.taap.2017.07.019. Epub 2017 Jul 26.

39.

A Short-Term Biological Indicator for Long-Term Kidney Damage after Radionuclide Therapy in Mice.

Pellegrini G, Siwowska K, Haller S, Antoine DJ, Schibli R, Kipar A, Müller C.

Pharmaceuticals (Basel). 2017 Jun 21;10(2). pii: E57. doi: 10.3390/ph10020057.

40.

Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.

Pauletti A, Terrone G, Shekh-Ahmad T, Salamone A, Ravizza T, Rizzi M, Pastore A, Pascente R, Liang LP, Villa BR, Balosso S, Abramov AY, van Vliet EA, Del Giudice E, Aronica E, Antoine DJ, Patel M, Walker MC, Vezzani A.

Brain. 2017 Jul 1;140(7):1885-1899. doi: 10.1093/brain/awx117. Retraction in: Brain. 2019 Jul 1;142(7):e38.

41.

Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy.

Walker LE, Frigerio F, Ravizza T, Ricci E, Tse K, Jenkins RE, Sills GJ, Jorgensen A, Porcu L, Thippeswamy T, Alapirtti T, Peltola J, Brodie MJ, Park BK, Marson AG, Antoine DJ, Vezzani A, Pirmohamed M.

J Clin Invest. 2017 Jun 1;127(6):2118-2132. doi: 10.1172/JCI92001. Epub 2017 May 15. Retraction in: J Clin Invest. 2019 Apr 8;129(5):2166.

42.

Age and gender considerations for technology-assisted delivery of therapy for substance use disorder treatment: A patient survey of access to electronic devices.

Antoine D, Heffernan S, Chaudhry A, King V, Strain EC.

Addict Disord Their Treat. 2016 Dec;15(4):149-156. doi: 10.1097/ADT.0000000000000088.

43.

The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation.

Yang H, Wang H, Wang Y, Addorisio M, Li J, Postiglione MJ, Chavan SS, Al-Abed Y, Antoine DJ, Andersson U, Tracey KJ.

J Intern Med. 2017 Jul;282(1):76-93. doi: 10.1111/joim.12619. Epub 2017 May 31.

44.

Characterization of Drug-Specific Signaling Between Primary Human Hepatocytes and Immune Cells.

Ogese MO, Faulkner L, Jenkins RE, French NS, Copple IM, Antoine DJ, Elmasry M, Malik H, Goldring CE, Park BK, Betts CJ, Naisbitt DJ.

Toxicol Sci. 2017 Jul 1;158(1):76-89. doi: 10.1093/toxsci/kfx069.

PMID:
28444390
45.

Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical Trials.

Longo DM, Generaux GT, Howell BA, Siler SQ, Antoine DJ, Button D, Caggiano A, Eisen A, Iaci J, Stanulis R, Parry T, Mosedale M, Watkins PB.

Clin Pharmacol Ther. 2017 Dec;102(6):961-969. doi: 10.1002/cpt.711. Epub 2017 May 27.

46.

Circulating levels of miR-122 increase post-mortem, particularly following lethal dosing with pentobarbital sodium: implications for pre-clinical liver injury studies.

Clarke JI, Forootan SS, Lea JD, Howell LS, Rodriguez JM, Kipar A, Goldring CE, Park BK, Copple IM, Antoine DJ.

Toxicol Res (Camb). 2017 Apr 11;6(4):406-411. doi: 10.1039/c6tx00442c. eCollection 2017 Jul 1.

47.

Laboratory-based biomarkers to improve causality assessment in drug-induced liver injury.

Antoine DJ.

Clin Liver Dis (Hoboken). 2017 Mar 1;9(2):38-42. doi: 10.1002/cld.611. eCollection 2017 Feb. Review. No abstract available.

48.

Optimising the use of medicines to reduce acute kidney injury in children and babies.

Oni L, Hawcutt DB, Turner MA, Beresford MW, McWilliam S, Barton C, Park BK, Murray P, Wilm B, Copple I, Floyd R, Peak M, Sharma A, Antoine DJ.

Pharmacol Ther. 2017 Jun;174:55-62. doi: 10.1016/j.pharmthera.2017.02.018. Epub 2017 Feb 12. Review.

PMID:
28202365
49.

Novel circulating- and imaging-based biomarkers to enhance the mechanistic understanding of human drug-induced liver injury.

Clarke JI, Brillanf N, Antoine DJ.

J Clin Transl Res. 2017 Feb 12;3(1):199-211. eCollection 2017 Feb 17. Review.

50.

Transformative biomarkers for drug-induced liver injury: are we there yet?

Antoine DJ, Dear JW.

Biomark Med. 2017 Feb;11(2):103-106. doi: 10.2217/bmm-2016-0338. Epub 2017 Jan 18. No abstract available.

Supplemental Content

Loading ...
Support Center